CN1272046C - Chinese medicine oral liquid for treating rheumatism - Google Patents

Chinese medicine oral liquid for treating rheumatism Download PDF

Info

Publication number
CN1272046C
CN1272046C CN 200410041513 CN200410041513A CN1272046C CN 1272046 C CN1272046 C CN 1272046C CN 200410041513 CN200410041513 CN 200410041513 CN 200410041513 A CN200410041513 A CN 200410041513A CN 1272046 C CN1272046 C CN 1272046C
Authority
CN
China
Prior art keywords
root
radix
oral liquid
principal agent
chinese medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 200410041513
Other languages
Chinese (zh)
Other versions
CN1613498A (en
Inventor
王�华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200410041513 priority Critical patent/CN1272046C/en
Publication of CN1613498A publication Critical patent/CN1613498A/en
Application granted granted Critical
Publication of CN1272046C publication Critical patent/CN1272046C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses a Chinese medicine oral liquid for treating rheumatism, which obtains extracts by that 1 wt% of main drugs are dipped and filtrated in 15 to 20 wt% of base wine. The main drugs are prepared from the following components of 9.6 wt % of black-tail snake, 8 wt % of wolfberry fruit, 7.2 wt % of spatholobus stem, 6.4 wt % of angelica, 6.4 wt % of notopterygium root, 6.4 wt % of pubescent angelica root, 6.4 wt % of epimedium, 5.6 wt % of venomin, 5.2 wt % of acanthopanax bark, 5.2 wt % of achyranthes root, 4.8 wt % of ledebouriella root, 4.8 wt % of safflower, 4 wt % of pawpaw, 4 wt % of mistletoe, 4 wt % of peach kernel, 3.6 wt % of clematis root, 3.6 wt % of ganoderma, 2.4 wt % of licorice root and 2.4 wt% of longan aril. The present invention has the advantages of wide sources of medicine materials, low cost and simple preparation; the present invention is used for treating rheumatism, rheumatoid arthritis, periarthritis of shoulders, cervical vertebra, pain on waists and legs, hyperosteogeny, numbness of limbs, grayish and yellowish complexion, etc.

Description

The Chinese medicine oral liquid and the compound method thereof of treatment rheumatism
Affiliated technical field
The present invention is specifically related to treat the Chinese medicine oral liquid and the compound method thereof of rheumatism.
Background technology
Rheumatism is a kind of pertinacious disease, does not have specific drug at present, and existing Chinese medicine and western medicine can only alleviating pain.
Summary of the invention
The objective of the invention is to: a kind of Chinese medicine oral liquid and compound method thereof for the treatment of rheumatism is provided, and relaxing muscles and tendons to promote blood circulation, chases after wind dehumidifying at building body, blood circulation promoting and blood stasis dispelling.
Technical solution of the present invention is: this oral liquid is soaked in wine base by principal agent and filters to get filtrate, principal agent and wine base weight ratio are 1: 15-20, principal agent by following component with the percentage by weight compatibility: Zaocys 9.6%, Fructus Lycii 8%, Caulis Spatholobi 7.2%, Radix Angelicae Sinensis, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, Herba Epimedii each 6.4%, Agkistrodon halys 5.6%, Cortex Acanthopancis, cattle sunset each 5.2%, Radix Saposhnikoviae, Flos Carthami each 4.8%, Fructus Chaenomelis, Herba Taxilli, Semen Persicae each 4%, Radix Clematidis, Ganoderma each 3.6%, Radix Glycyrrhizae, each 2.4%. of Arillus Longan
This oral liquid compounding method is as follows: 1, select principal agent raw material, oven dry, broken coarse powder; 2, medicated powder is put in the container, adds 15-20 times of wine base of principal agent weight in the container and soaks 10-20 days; 3, filter waste and get filtrate, packing on request leaves standstill, filters, sterilizes.
Using method: every day 1-2 time, each 15ml, drink-service several times, the alcohol user does not drink after diluting with cold water several times.
This oral medicine medical material is extensive, with low cost, and preparation is simple, is used for the treatment of diseases such as rheumatism, rheumatoid arthritis, scapulohumeral periarthritis, cervical spondylosis, lumbago and skelalgia, hyperosteogeny, numb limbs and tense tendons, yellowish and gloomy complexion.
The specific embodiment
Embodiment 1:1, select principal agent raw material, oven dry, broken coarse powder; 2, joining 250g medicated powder with Zaocys 24g, Fructus Lycii 20g, Caulis Spatholobi 18g, Radix Angelicae Sinensis, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, each 16g of Herba Epimedii, Agkistrodon halys 14g, Cortex Acanthopancis, each 13g of cattle sunset, Radix Saposhnikoviae, each 12g of Flos Carthami, Fructus Chaenomelis, Herba Taxilli, each 10g of Semen Persicae, Radix Clematidis, each 9g of Ganoderma, Radix Glycyrrhizae, each 6g of Arillus Longan puts in the container; 3, add 4000g55 degree soaking in Chinese liquor 15 days in the container; 4, filter waste and get filtrate, packing on request leaves standstill, filters, sterilizes.
Embodiment 2:1, select principal agent raw material, oven dry, broken coarse powder; 2, joining 250g medicated powder with Zaocys 24g, Fructus Lycii 20g, Caulis Spatholobi 18g, Radix Angelicae Sinensis, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, each 16g of Herba Epimedii, Agkistrodon halys 14g, Cortex Acanthopancis, each 13g of cattle sunset, Radix Saposhnikoviae, each 12g of Flos Carthami, Fructus Chaenomelis, Herba Taxilli, each 10g of Semen Persicae, Radix Clematidis, each 9g of Ganoderma, Radix Glycyrrhizae, each 6g of Arillus Longan puts in the container; 3, add 5000g55 degree soaking in Chinese liquor 20 days in the container; 4, filter waste and get filtrate, packing on request leaves standstill, filters, sterilizes.
Embodiment 3:1, select principal agent raw material, oven dry, broken coarse powder; 2, joining 250g medicated powder with Zaocys 24g, Fructus Lycii 20g, Caulis Spatholobi 18g, Radix Angelicae Sinensis, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, each 16g of Herba Epimedii, Agkistrodon halys 14g, Cortex Acanthopancis, each 13g of cattle sunset, Radix Saposhnikoviae, each 12g of Flos Carthami, Fructus Chaenomelis, Herba Taxilli, each 10g of Semen Persicae, Radix Clematidis, each 9g of Ganoderma, Radix Glycyrrhizae, each 6g of Arillus Longan puts in the container; 3, add 4500g55 degree soaking in Chinese liquor 20 days in the container; 4, filter waste and get filtrate, packing on request leaves standstill, filters, sterilizes.

Claims (3)

1, the Chinese medicine oral liquid of treatment rheumatism, it is characterized in that: this oral liquid is soaked in wine base by principal agent and filters to get filtrate, principal agent and wine base weight ratio are 1: 15-20, principal agent by following component with the percentage by weight compatibility: Zaocys 9.6%, Fructus Lycii 8%, Caulis Spatholobi 7.2%, Radix Angelicae Sinensis, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, Herba Epimedii each 6.4%, Agkistrodon halys 5.6%, Cortex Acanthopancis, cattle sunset each 5.2%, Radix Saposhnikoviae, Flos Carthami each 4.8%, Fructus Chaenomelis, Herba Taxilli, Semen Persicae each 4%, Radix Clematidis, Ganoderma each 3.6%, Radix Glycyrrhizae, Arillus Longan each 2.4%.
2, the compound method of the Chinese medicine oral liquid of treatment rheumatism according to claim 1 is characterized in that: 1, select principal agent raw material, oven dry, broken coarse powder; 2, medicated powder is put in the container, adds 15-20 times of wine base of principal agent weight in the container and soaks 10-20 days;
3, filter waste and get filtrate, packing on request leaves standstill, filters, sterilizes.
CN 200410041513 2004-07-24 2004-07-24 Chinese medicine oral liquid for treating rheumatism Expired - Fee Related CN1272046C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200410041513 CN1272046C (en) 2004-07-24 2004-07-24 Chinese medicine oral liquid for treating rheumatism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200410041513 CN1272046C (en) 2004-07-24 2004-07-24 Chinese medicine oral liquid for treating rheumatism

Publications (2)

Publication Number Publication Date
CN1613498A CN1613498A (en) 2005-05-11
CN1272046C true CN1272046C (en) 2006-08-30

Family

ID=34763707

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200410041513 Expired - Fee Related CN1272046C (en) 2004-07-24 2004-07-24 Chinese medicine oral liquid for treating rheumatism

Country Status (1)

Country Link
CN (1) CN1272046C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102441088B (en) * 2011-11-30 2014-04-02 宋爱民 Traditional Chinese medicinal liquor used for treating lumbar muscle fiber inflammation
CN102671120A (en) * 2012-05-02 2012-09-19 成都黄再军医院 Traditional Chinese medicine and method for preparing same

Also Published As

Publication number Publication date
CN1613498A (en) 2005-05-11

Similar Documents

Publication Publication Date Title
CN1317027C (en) Chinese medicine for treating depression
CN102614377A (en) Method for preparing life-prolonging health-care wine
CN1278446A (en) Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease
CN105381135A (en) Wind-dispelling, blood-activating and kidney-tonifying health-maintaining wine
CN1322885C (en) Plaster medicine composition with multiple purpose for treating affection pain due to dampness
CN104107289A (en) Traditional Chinese medicinal composition for treating orthopedic diseases
CN1085089C (en) Medicine for treating sciatica
CN101244235B (en) Scraping oil, preparation method and application thereof
CN1272046C (en) Chinese medicine oral liquid for treating rheumatism
CN101152352A (en) Traditional Chinese medicine for treating intestinal abscess
CN102552708A (en) Medicinal composition for calming liver wind
CN103316228A (en) Scorpio unsting wine
CN105688059A (en) Traditional Chinese medicine preparation with folium artemisiae argyi for treating osteoproliferation through external application
Tierra Healing with the Herbs of Life: Hundreds of Herbal Remedies, Therapies, and Preparations
CN105125658A (en) Granules with effects of eliminating obstruction to activate collaterals and preparation method thereof
CN1283284C (en) Medicinal spirit for rheumatism
CN1060076C (en) Gucixiao pill for removing spur
CN105617012A (en) Traditional Chinese medicine composition for treating constipation
CN104523959B (en) A kind of health care massage zaocys dhumnades olein
CN102258631B (en) Chinese medicinal preparation for treating osteoproliferation and gout
CN1457826A (en) Capsule for killing pain and recovery
CN104887874A (en) Traditional Chinese medicine composition for treating pneumonia
CN1223358C (en) Chinese medicinal herbs preparation 'Shuzetong' for treating hydrops
CN104013829A (en) Traditional Chinese medicine composition for treating premonitory apoplexy
CN112057527A (en) A Chinese medicinal hot topical plaster for treating pain and bone injury, and its preparation method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee